Anna Seekatz is an Assistant Professor in the Department of Biological Sciences at Clemson University, affiliated with the College of Science. Her research focuses on the gut microbiome, particularly its role in health and disease, with emphasis on Clostridioides difficile infection (CDI) and fecal microbiota transplantation (FMT). She received her PhD from the University of Maryland School of Medicine and completed postdoctoral training at the University of Michigan. Education : PhD, Molecular Microbiology and Immunology, University of Maryland School of Medicine, 2013 BS, Cellular and Molecular Biology, Western Washington University, 2006 Research Interests : Dr. Seekatz studies microbial interactions within the gut microbiota, including CDI pathogenesis and FMT mechanisms. Her lab investigates how microbial communities contribute to disease resistance and recovery, with a focus on identifying key species and metabolites involved in CDI clearance. Current projects include characterizing commensal Clostridia and their functional dependencies in the gut environment. Techniques employed include bioinformatics, animal models, and traditional microbiology. Lab & Advising : Her research group includes PhD students Sophie Millard, Clara Flores, Christine Woelfel-Monsivais, and postdoctoral fellow Disha Bhattacharjee. She teaches Pathogenic Bacteriology and a creative inquiry course on commensal Clostridia characterization. Lab Locations : Life Sciences Building 157A (Office), 160F and 172 (Labs).
Dr. John Rohde is an Associate Professor in the Department of Microbiology & Immunology at Dalhousie University's Faculty of Medicine. His research focuses on understanding mechanisms of bacterial pathogenesis, particularly how Shigella spp. exploits host cell systems. He holds a PhD in Biochemistry from the University of British Columbia and completed postdoctoral training at Duke University, Institut Pasteur, and Mount Sinai Hospital's Samuel Lunenfeld Research Institute. His lab develops genetic tools to study bacterial virulence at systems levels. Education: BS/MS in Bacteriology (University of Idaho), PhD in Biochemistry (UBC) Research Interests: Shigella pathogenesis, ubiquitin ligases, type III secretion systems Recent work includes studies on Shigella's manipulation of host actin via RACK1 and the role of ubiquitin in pathogen survival. He collaborates internationally on projects combining proteomics and immunology to uncover antimicrobial defense mechanisms.
Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.
Yibing Qyang is a Professor of Medicine (Cardiovascular Medicine) at Yale University School of Medicine (YSM), affiliated with the Department of Internal Medicine. He serves as Director of the Yale Stem Cell Research Forum since 2010. His expertise spans stem cell biology, cardiovascular disease modeling, and regenerative medicine. Qyang holds a B.S. from Nanjing University, an M.S. from Chinese Academy of Sciences, and a Ph.D. from the University of Texas M.D. Anderson Cancer Center. He completed postdoctoral training at UC San Diego and Harvard Medical School. Research Interests: The Qyang Lab focuses on engineering vascular tissues using induced pluripotent stem cells (iPSCs), elucidating cardiovascular disease mechanisms, and developing therapeutic strategies. Key areas include: Vascular tissue engineering for graft development Stem cell-derived models of diseases like supravalvular aortic stenosis Cardiac progenitor cell therapies for heart repair Biomechanical signaling in hypertrophic cardiomyopathy Preclinical porcine models for translational research Key Achievements: Developed immunocompatible 'universal donor' vascular grafts using CRISPR-engineered iPSCs Pioneered iPSC-derived vascular smooth muscle and endothelial cells for tissue engineering Identified elastin-based therapies for supravalvular aortic stenosis Grants & Awards: Connecticut Stem Cell Program Established Investigator Awards (2011, 2015) ISSCR Membership (2007–Present) Highlighted in Yale News for groundbreaking discoveries in heart disease and vascular grafts Lab Team & Collaborations: The lab includes researchers and students from institutions worldwide, with collaborations at Harvard, UCSD, and Yale’s Cardiovascular Research Center. Projects span iPSC differentiation, biomechanical modeling, and preclinical trials. Future Directions: Expanding studies on universal donor grafts, cardiac tissue engineering, and clinical translation of iPSC-derived therapies.
Stelios Andreadis is the SUNY Distinguished Professor of Chemical and Biological Engineering at the University at Buffalo, affiliated with the School of Engineering and Applied Sciences. He directs the Cell, Gene and Tissue Engineering Center and previously led the Stem Cells in Regenerative Medicine (SCiRM) Training Program. His research focuses on stem cell bioengineering, vascular and gland tissue engineering, and biomaterials design. He holds a PhD in Chemical Engineering from the University of Michigan and has been funded by NIH, NSF, and NYSTEM, totaling over $20M. His awards include the NSF CAREER Award, SUNY Chancellor’s Excellence in Scholarship, and AIMBE and BMES Fellowships. Research interests span stem cell rejuvenation, cell-free vascular grafts, and metabolic reprogramming. He has published 140+ papers and advised 28 PhD students, many now in academia or industry. His lab co-founded Angiograft, LLC to commercialize vascular grafts. Key achievements include developing self-healing vascular grafts and demonstrating monocyte recruitment for vascular regeneration. His work bridges basic science and clinical applications in regenerative medicine.
Quan Liu, M.D., Ph.D., is an Associate Professor at the School of Medicine, Southern University of Science and Technology (SUSTech), where he has been employed since August 2018. He also serves as Deputy Secretary of the Joint Party Committee of the School of Medicine, Chairman of the Joint Labor Union of the School of Medicine, and Vice Chairman of the Transplant Immunology Professional Committee of the Immunotherapy Engineering Branch of the Chinese Society of Biomedical Engineering. Additionally, he holds the position of Associate Chief Physician at the Second Affiliated Hospital of Harbin Medical University. Dr. Liu received his Medical Degree (M.D.) from Harbin Medical University in 2002, followed by surgical training at the Second Affiliated Hospital of Harbin Medical University from 2002 to 2008, specializing in cardiothoracic surgery. He pursued his Ph.D. at the University of Pittsburgh, where he spent over 8 years (2009-2017) at the Thomas E. Starzl Transplantation Institute studying transplantation immunobiology, inflammation regulation, and immunobiology of IL-33 and regulatory T cells (Treg) with Drs. Heth Turnquist and Adrian Morelli. Dr. Liu's research focuses on three primary areas: (1) Alloantigen presentation in transplantation, (2) Immunobiology of IL-33, Treg and ILC2 in settings of transplantation, inflammation regulation and tumor, and (3) Immunotherapy. His work has made significant contributions to the field of transplant immunology, particularly in elucidating the role of donor dendritic cell-derived exosomes in mediating the semi-direct pathway of alloantigen presentation, revealing the role of intra-allograft recipient-derived dendritic cells in maintaining transplant rejection, and investigating the role of IL-33 in tissue protection during acute lung injury and heart transplant rejection. His research findings have been included in the classic immunology textbook Janeway's Immunobiology (10th Ed, 2022). Dr. Liu's publications demonstrate a strong focus on immunology, particularly transplant immunology, with recurring themes of IL-33, regulatory T cells, and mechanisms of immune regulation in transplantation settings. His work spans from basic immunological mechanisms to potential clinical applications in transplantation and cancer. Provincial Science and Technology Progress Second Prize (2007) Provincial Science and Technology Progress Second Prize (2008) Young Scientist Award at the American Transplant Congress (2013) Distinguished Young Talents project of the Second Affiliated Hospital of Harbin Medical University (2017) Dr. Liu has successfully completed a National Natural Science Foundation of China Youth Fund project and is currently leading a National Natural Science Foundation of China General Project (2020-2023). He has supervised doctoral students and has been actively involved in teaching undergraduate courses in Biochemistry, Physiology, and Pathophysiology, as well as graduate courses in Immunology. His laboratory at SUSTech has developed advanced research capabilities including over 30 mouse strains (more than 10 developed independently), access to a Seahorse XFe96 cell energy metabolism analyzer, and a CyTOF Helios mass cytometer for advanced immunological studies. Dr. Liu leads a research group at SUSTech focused on tumor immunity and immunotherapy, neuro-immune-metabolic interactions, and transplant immunity. The laboratory has established significant experimental capabilities including over 30 mouse strains (more than 10 developed independently), access to a Seahorse XFe96 cell energy metabolism analyzer for immunometabolism research, and a CyTOF Helios mass cytometer for advanced immunological studies.
Florent Ginhoux serves as a Senior Principal Investigator at the Singapore Immunology Network (SIgN), A*STAR, and holds adjunct associate professor positions across Singapore's academic landscape including the Yong Loo Lin School of Medicine at National University of Singapore, Duke-NUS Medical School, Skin Research Institute of Singapore, and Nanyang Technological University's School of Biological Sciences, with additional affiliation at Shanghai Immunology Institute. His academic foundation was established in France: Biochemistry degree from University Pierre et Marie Curie (UPMC), Paris VI Masters in Immunology from Pasteur Institute (2000) PhD from UPMC, Paris VI (2004) Following postdoctoral training at Mount Sinai School of Medicine under Dr. Miriam Merad, he joined SIgN in 2009 after serving as Assistant Professor at Mount Sinai. His laboratory pioneers research on dendritic cell and macrophage ontogeny using high-dimensional platforms including RNA sequencing, single-cell transcriptomics, and mass cytometry (CyTOF) to define cell populations by developmental origin and uncover their specialized immune functions. Recognized as an EMBO Young Investigator, his work bridges fundamental immunology with therapeutic applications for immune pathologies. His mentoring includes PhD student Katharine YANG and postdoctoral researchers Satish Tiwari, Sulvania Susanto, Priya Dhami, and William Ho. The lab actively collaborates on immunomonitoring projects leveraging SIgN's advanced platforms for high-dimensional immune profiling in both human and murine systems.
Liza M. Roger is an Assistant Professor in the School of Molecular Sciences at Arizona State University (ASU) and a Senior Global Futures Scientist at the Global Futures Scientists and Scholars Program. She is affiliated with the School of Ocean Futures and works at the Walton Center for Planetary Health. Education: Ph.D. in Marine Biology and Geochemistry (University of Western Australia, 2017) B.Sc. Hon. in Marine Biology and Natural Resources Management (University of Western Australia, 2011) Associate’s Degree (Université du Littoral Côte d’Opale, France, 2006) Her research explores how environmental change affects marine organisms in symbiotic relationships with microscopic algae, such as corals, mollusks, anemones, and jellyfish. She pioneers coral in vitro methodologies to advance understanding of symbiosis, biomineralization, and stress adaptation. Recent publications highlight her work on nanotechnology for coral reef conservation, thermal stress mitigation using engineered nanoceria, and interdisciplinary collaborations merging art with coral research. Her studies also address trace metal roles in coral nutrition, insulin signaling pathways, and innovative imaging techniques to monitor coral health. Scientific Awards: NSF’s 2021 Coral Bleaching Research Coordination Network Early Career Training Program Award VCU’s 2021 Postdoctoral Independent Research Award Liza’s multidisciplinary approach integrates expertise from oceanography, biochemistry, nanoscience, and sustainability. She previously worked at the Australian Institute of Marine Science and has field experience as a cetacean naturalist in Iceland and a scuba diving instructor in the Mediterranean Sea and Southeast Asia.
Ralf Zimmer is a Full Professor for Practical Informatics and Bioinformatics at Ludwig Maximilian University of Munich (LMU) since 2001, affiliated with the Department of Informatics in the Faculty of Mathematica, Informatics and Statistics. He concurrently serves as Head of Section III and Head of the Research Group Network Regulation and Modeling / Machine Learning at the Leibniz Institute for Food Systems Biology at TUM (Leibniz-LSB@TUM) in Freising, Germany. His academic foundation includes a Diploma with distinction in Computer Science, Applied Mathematics and Operations Research from the University of Bonn (1981-1986), followed by a summa cum laude Doctorate in Computer Science and Applied Mathematics from CAU Kiel in 1990, where he received dual honors: the CAU Dissertation Award and Best Dissertation Award. Zimmer's research pioneers the integration of bioinformatics, systems biology, and machine learning to decode molecular food-consumer interactions. His group develops causal system models for biological networks, validated through in silico simulations and multi-omics perturbation experiments (transcriptomics/proteomics). Core methodologies include network regulation modeling, algorithmic bioinformatics, and database construction linking food compounds to biochemical networks and cellular phenotypes, with translational goals for food and biotech innovation. His 14 most recent publications (2012-2024) reveal dominant trends in multi-omics immunology and cardiovascular research, featuring computational innovations for high-throughput data analysis. Key themes include host-pathogen dynamics (viral infections), inflammatory disease mechanisms (atherosclerosis), and methodological advances in proteomics/transcriptomics, consistently bridging fundamental bioinformatics with clinical applications. Major scientific recognitions include: CAU Dissertation Award and Best Dissertation Award (1990) Director of LMU's Informatics Department (2010-2012) DFG Review Board membership for biomedical foundations (2008-2016) Leadership of the DFG Bioinformatics Munich Center (2001-2008) Academic Senate election at LMU München (2011) Zimmer directs LMU/TUM's joint B.Sc./M.Sc. bioinformatics programs since 2001 as founding architect of the DFG-funded Bioinformatics Munich initiative. His educational leadership spans spokesperson roles for international training groups (IRTG RECESS), collaborative research centers (SFB1123 Atherosclerosis), and elite programs (Data Science, Munich Center for Machine Learning). Grant stewardship includes directing the DFG Bioinformatics Munich Center and shaping national funding policy via the DFG review board. At Leibniz-LSB@TUM, his research group pioneers databases connecting food compounds to cellular phenotypes through molecular networks, collaborating with Munich universities, clinics, and biotech partners to develop high-throughput sequencing/proteomics applications for future food and health innovations.
Priyanka Pundir is an Assistant Professor in the Department of Molecular and Cellular Biology at the University of Guelph. Her research focuses on innate immunity, particularly mast cell-mediated host-microbe interactions, and the role of G protein-coupled receptors (GPCRs) in immune responses against infections. She holds a B.V.Sc. from G. B. Pant University of Agriculture & Technology, a Ph.D. from the Atlantic Veterinary College (University of Prince Edward Island), and completed postdoctoral training at Johns Hopkins University. Education: B.V.Sc. – College of Veterinary Sciences, G. B. Pant University of Agriculture & Technology Ph.D. – Atlantic Veterinary College, University of Prince Edward Island Postdoctoral Fellowship – School of Medicine, Johns Hopkins University Her lab investigates how mast cells detect microbial signals (e.g., quorum-sensing molecules) and trigger immune defenses. Key discoveries include identifying the Mrgprb2 receptor’s role in antibacterial immunity and its implications for therapeutic development. Current projects explore neuroimmune interactions during infections and the functions of orphan Mrgprs. Her lab actively recruits motivated students and offers a PhD position starting in 2024. Contact: ppundir@uoguelph.ca .
Dr. Ype P. de Jong is an Assistant Professor of Medicine at Weill Cornell Medical College of Cornell University and an Attending Physician at New York-Presbyterian Hospital. He completed his medical and doctoral training at the University of Amsterdam, followed by internal medicine and gastroenterology fellowships at Mount Sinai Hospital, New York. His research focuses on hepatitis virus immune evasion, liver disease modeling, and gene therapy applications. Education M.D., University of Amsterdam Faculty of Medicine (2003) Ph.D., University of Amsterdam (2002) Research Interests Dr. de Jong investigates hepatitis virus persistence mechanisms, develops advanced liver disease models, and explores gene therapy applications for hemophilia and liver conditions. His work bridges clinical hepatology with translational research on viral immune evasion and hepatocyte engineering. Scientific Awards Cum Laude (PhD thesis), University of Amsterdam (2002) Hippocrates Prize (Best Medical Thesis in Netherlands), Leiden University (2003) Appointments Assistant Professor of Medicine, Weill Cornell Medical College Attending Physician, New York-Presbyterian Hospital Visiting Clinical Fellow, The Rockefeller University
Edel Hyland is a Senior Lecturer in Biochemistry at Queen's University Belfast's School of Biological Sciences, affiliated with the Institute for Global Food Security since 2015. Her research examines how genome architecture influences environmental adaptation through chromatin dynamics, utilizing yeast pathogens from the Saccharomycotina subphylum with active PhD recruitment in antifungal resistance. Her academic training includes a BSc in Biochemistry from Trinity College Dublin (1996-2000), PhD under Prof. Jef Boeke at Johns Hopkins School of Medicine (2002-2008), and postdoctoral work at Harvard Medical School (2001-2002), Harvard University (2009-2014), and Dublin City University (2014-2015). Research centers on chromatin-based gene regulation mechanisms across evolutionary timescales, specifically investigating: experimental evolution of Saccharomyces cerevisiae histone variants, CRISPR-Cas9 reverse genetics in Candida glabrata virulence, and comparative epigenomics of histone marks in fungal pathogens. This work directly addresses antifungal resistance and phenotypic plasticity in human-infecting yeasts. Recent publications (2019-2023) reveal strong interdisciplinary trends combining medical mycology with evolutionary genomics, particularly in Candida drug resistance mechanisms. Parallel work extends to malaria pathogenesis (Plasmodium transporters) and innate immune evolution, consistently applying chromatin analysis to pathogen adaptation challenges. She holds the Charles A. King Postdoctoral Fellowship award and serves as Co-Investigator on two major research projects: IMMACULATE: Improving Mass Spectrometry Sustainability in Food, Environmental, and Health Research (2023-present) Phosphorus from wastewater: Novel technologies for advanced treatment and re-use (2014-present) Hyland coordinates undergraduate Experimental Biochemistry (BIO2102) and MSc Protein Structure & Function (BBC8039) modules while actively supervising PhD students. Her laboratory focuses on yeast epigenetics within the Institute for Global Food Security, maintaining international collaborations evidenced by co-author networks spanning the USA, Ireland, and UK, and participates in science outreach including the Northern Ireland Science Festival.
Dr. Zakia Djaoud is an Assistant Professor at the Department of Biochemistry, Microbiology and Immunology (University of Ottawa) and a Scientist at the CHEO Research Institute . Her research focuses on human innate lymphocytes, particularly γδ T cells and NK cells, and their roles in viral infections (e.g., herpesviruses), cancer, and transplantation. She employs advanced techniques like functional immunology, T-cell receptor repertoire analysis, immunogenetics, flow cytometry, mass cytometry, and high-throughput gene sequencing. Education : DVM (Higher National Veterinary School of Algiers), MSc (Paris Descartes/Paris-Est Créteil), PhD (University of Nantes, Human Immunology) Postdoctoral Training : Stanford University, laboratory of Dr. Peter Parham Her recent publications explore HLA-KIR-TCR interactions, viral immune evasion, and lymphocyte functional education. She has contributed to understanding Epstein-Barr virus and CMV immunity, with a focus on receptor polymorphisms and immune cell dynamics. Dr. Djaoud's lab investigates how immunogenetics and herpesvirus infections shape innate lymphocyte repertoires and functional responses.
Nevil Singh is an Associate Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine, where he has been a faculty member since 2013. He is also a Member of the Marlene and Stewart Greenebaum Comprehensive Cancer Center. His research focuses on understanding the mechanisms of T cell activation, tolerance, and memory formation. Dr. Singh received his graduate training at the Tata Institute of Fundamental Research (TIFR) in Bombay, India, where he worked on vaccine-antigens against the malarial parasite Plasmodium falciparum . He then completed a post-doctoral fellowship with Ron Schwartz's group at the NIAID, NIH, examining T cell tolerance to self-proteins. Following this, he worked as a Research Scientist at the NIAID studying mechanisms controlling the responsiveness and frequency of helper T cells. Dr. Singh's research spans several interconnected areas in immunology. His laboratory investigates how T cells discriminate between pathogens, tumors, and self-antigens through mechanisms of negative regulatory signaling. They study how T cells calibrate their sensitivity to antigen through a process called "T cell tuning." The lab also examines how T cell responses are tailored to both pathogen type and affected tissue niche. Additionally, they investigate the mechanisms by which neurotransmitters regulate T cell function, exploring the intersection of nervous and immune systems. Dr. Singh's research has significant implications for understanding autoimmune diseases, developing more effective vaccines, and improving cancer immunotherapies. His work on T cell tuning provides insights into how the immune system maintains tolerance to self-antigens while remaining responsive to pathogens, with potential applications for treating both autoimmune disorders and cancer. Dr. Singh has received funding from diverse sources including DARPA for his work on immunological memory formation. His laboratory collaborates with teams at UMSOM, Arizona State University, and the NIAID/NIH in Bethesda, and with the Fuerst group at IBBR for preclinical HCV vaccine evaluation. Dr. Singh actively mentors graduate students and postdoctoral fellows, with several former trainees now in prominent positions in academia and industry. His laboratory culture emphasizes both experimental training and intellectual development, encouraging independent thinking and project development skills.
Christopher Grainge is a Conjoint Associate Professor at the University of Newcastle's School of Medicine and Public Health, and a Staff Specialist in Respiratory and General Medicine at John Hunter Hospital. Previously, he served as a Consultant Physician and Senior Lecturer at the University of Southampton. His extensive clinical background includes service in the Royal Navy, specializing in diving and remote medicine, and deployments to Antarctica and Southern Iraq. Dr. Grainge maintains active research collaborations with institutions worldwide, focusing on respiratory medicine. Dr. Grainge completed his undergraduate training at Imperial College, University of London, with an intercalated BSc. He earned his PhD from the University of Southampton in 2011, with research published in the New England Journal of Medicine. His thesis examined the effect of repeated bronchoconstriction on airways in asthma. He also holds membership in the Royal College of Physicians and was awarded the Diploma in the Medical Care of Catastrophes, specializing in remote and refugee medicine. Dr. Grainge's research focuses on the role of mechanical forces in asthma pathophysiology, environmental dusts in lung disease development, and platelet antagonists' effects on allergen challenge. His work demonstrates that mechanical forces play a crucial role in determining long-term changes in human airways. He leads investigations into how environmental exposure to inhaled particles leads to conditions like constrictive bronchiolitis, and explores novel therapeutic pathways for asthma through platelet activation inhibition. His research has significant clinical implications for difficult asthma and interstitial lung disease management. Dr. Grainge's recent publications reflect strong trends in interstitial lung disease research, particularly idiopathic pulmonary fibrosis, and asthma mechanisms. His work increasingly incorporates advanced technologies like artificial intelligence for disease stratification and deep learning for predicting disease progression. Collaborative research with international teams examines biomarkers for disease progression and novel treatment approaches for fibrotic lung diseases, with a particular focus on quantitative CT analysis and patient-reported outcome measures. Leatherdale Prize for Clinical Teaching: Finalist (2013) Military and Civilian Health Partnership Awards Winner (2011) University of Southampton Translational Medicine Research Prize (2011) Michael Arthur Clinical Research Prize (2014) British Lung Foundation Travel Fellowship (2011) Gilbert Blane Medal (2010) Colt Foundation Prize: Finalist (2010) Asthma UK Travel Fellowship (2009) Dr. Grainge has received significant research funding from the British Lung Foundation, the Southampton Marine and Maritime Institute, the Institute for Life Sciences, and the Gerald Kerkut Foundation. His projects investigate the effects of physical and environmental stress on lung disease, mechanisms underlying lung disease development following environmental particle exposure, and potential therapies. He has collaborated extensively with research teams across Australia, the UK, the Netherlands, and South Africa, contributing to the training of numerous students and junior researchers through his supervision and mentorship roles. Dr. Grainge collaborates extensively with the Respiratory Research group at the University of Southampton, the Asthma and COPD Research Group at the University of Groningen in the Netherlands, and the Microbiome group at the South Australia Medical Research Institute. His current work at the Hunter Medical Research Institute (HMRI) focuses on mechanical forces within airways and their impact on acute and long-term lung changes in patients with airway diseases. He is also involved in the Australian IPF Registry, contributing to multicenter studies on idiopathic pulmonary fibrosis progression and treatment outcomes.
